You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

P2X3 receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cough Trial (device, diagnostic test, procedure)

Not yet recruiting
  • Cough
  • Adenosine triphosphate (ATP) solution inhalation from nebuliser
  • +7 more
  • (no location specified)
Jan 26, 2023

Idiopathic Pulmonary Fibrosis, Cough Trial (Gefapixant, Placebo)

Completed
Has Results
  • Idiopathic Pulmonary Fibrosis
  • Cough
  • (no location specified)
Apr 30, 2021

Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

Recruiting
  • Breast Cancer
  • Bowral, New South Wales, Australia
  • +37 more
Aug 8, 2022

Chronic Cough Trial (Gefapixant, Placebo)

Completed
Has Results
  • Chronic Cough
  • (no location specified)
Nov 10, 2020

Drug Interactions Trial in Daytona Beach (Rosuvastatin, Rosuvastatin + BAY1817080)

Completed
  • Drug Interactions
  • Daytona Beach, Florida
    Covance Clinical Research Unit, Inc.
Mar 9, 2021

Glioblastoma Trial (PET imaging)

Not yet recruiting
  • Glioblastoma
  • PET imaging
  • (no location specified)
Feb 23, 2023

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Phoenix, Arizona
  • +88 more
Jan 19, 2023

Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

Active, not recruiting
  • Neuroblastoma
  • iC9-GD2 T Cells - frozen
  • +5 more
  • Houston, Texas
  • +1 more
Jan 4, 2023

Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

Not yet recruiting
  • Neuroendocrine Tumors
  • Lutetium[177Lu] Oxodotreotide Injection
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 30, 2023

Obstructive Sleep Apnea Trial (IHL-42X Low Dose, IHL-42X High Dose, Placebo)

Not yet recruiting
  • Obstructive Sleep Apnea
  • IHL-42X Low Dose
  • +5 more
  • (no location specified)
Nov 22, 2023

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL Trial in Calgary, Edmonton (autologous CD19-directed

    Recruiting
    • Relapsed Non Hodgkin Lymphoma
    • +2 more
    • autologous CD19-directed chimeric antigen receptor (CAR) T-cells
    • Calgary, Alberta, Canada
    • +5 more
    Jul 18, 2022

    Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

    Recruiting
    • Locally Advanced or Unresectable Metastatic Breast Cancer
    • Stage IV Breast Cancer
    • Sacituzumab Govitecan-hziy
    • +3 more
    • Marietta, Georgia
    • +1 more
    Apr 21, 2023

    Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))

    Recruiting
    • Breast Cancer
    • Saint Louis, Missouri
    • +2 more
    Jan 12, 2023

    Dopamine Receptor Binding in Treatment Resistant Depression

    Not yet recruiting
    • Treatment Resistant Depression
    • PET scans
    • (no location specified)
    Nov 9, 2022

    Polycystic Ovary Syndrome Trial (SGLT2 inhibitors combined with metformin, Placebo combined with metformin)

    Not yet recruiting
    • Polycystic Ovary Syndrome
    • SGLT2 inhibitors combined with metformin
    • Placebo combined with metformin
    • (no location specified)
    Jul 21, 2023

    Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

    Recruiting
    • Breast Cancer
    • ARV-471 (PF-07850327)
    • +2 more
    • Orange City, Florida
      Mid Florida Hematology and Oncology Center
    Jun 8, 2023

    Primary Breast Cancer Trial (SPECT)

    Not yet recruiting
    • Primary Breast Cancer
    • (no location specified)
    Jun 19, 2023

    Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)

    Enrolling by invitation
    • Dopamine D2/3 Receptor Availability
    • +2 more
    • Los Angeles, California
      University of California Los Angeles
    Mar 2, 2022

    Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)

    Completed
    • Healthy
    • R1: Reference Product X
    • +12 more
    • Nottingham, United Kingdom
      Quotient Sciences
    Dec 7, 2022

    Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

    Recruiting
    • Lung Cancer
    • Neuroendocrine Neoplasm
    • Beijing, Beijing, China
      Peking Union Medical College Hospitall, Chinese Academy of Medic
    Mar 30, 2022